RSVAX
Price
$26.05
Change
+$0.21 (+0.81%)
Updated
Dec 3 closing price
Net Assets
255.38M
VMVIX
Price
$69.65
Change
+$0.49 (+0.71%)
Updated
Dec 3 closing price
Net Assets
31.8B
Interact to see
Advertisement

RSVAX vs VMVIX

Header iconRSVAX vs VMVIX Comparison
Open Charts RSVAX vs VMVIXBanner chart's image
Victory RS Value A
Price$26.05
Change+$0.21 (+0.81%)
VolumeN/A
Net Assets255.38M
Vanguard Mid-Cap Value Index Investor
Price$69.65
Change+$0.49 (+0.71%)
VolumeN/A
Net Assets31.8B
RSVAX vs VMVIX Comparison Chart in %
View a ticker or compare two or three
VS
RSVAX vs. VMVIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSVAX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 31.8B vs. RSVAX (255M). VMVIX pays higher dividends than RSVAX: VMVIX (2.02) vs RSVAX (0.36). RSVAX was incepted earlier than VMVIX: RSVAX (32 years) vs VMVIX (19 years). RSVAX (1.33) is less costly to investors than VMVIX (0.19). RSVAX is a more actively managed with annual turnover of: 39.00 vs. VMVIX (19.00). RSVAX has a lower initial minimum investment than VMVIX: RSVAX (2500) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 0.92 vs. RSVAX (-9.99). VMVIX return over 5 years is better than : 51.17 vs. RSVAX (14.68).
RSVAXVMVIXRSVAX / VMVIX
Total Expense Ratio1.300.19684%
Annual Report Gross Expense Ratio1.330.19700%
Fund Existence32 years19 years-
Gain YTD4.2949.02448%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets255M31.8B1%
Annual Yield % from dividends0.362.0218%
Returns for 1 year-9.990.92-1,090%
Returns for 3 years-0.2124.50-1%
Returns for 5 years14.6851.1729%
Returns for 10 years-15.15101.93-15%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEOPX67.21N/A
N/A
BNY Mellon S&P 500 Index
CENTX14.36N/A
N/A
Centerstone Investors I
JERNX12.34N/A
N/A
Janus Henderson Global Real Estate N
IGIIX43.55N/A
N/A
Nomura Global Growth Fund Class I
RRMVX32.34N/A
N/A
T. Rowe Price Mid-Cap Value R